drugset / Trial / NCT06576882

7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

NCT06576882

Phase 3 Completed 326 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to test the efficacy of 7 days vs. 14 days of Vonoprazan-triple therapy in the eradication of Helicobacter Pylori infection in adolescents and young children.

Timeline

Start
2024-06-30
Primary completion
2024-11-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 50 mg/kg Oral
Subject Clarithromycin Small molecule 20 mg/kg Oral
Subject Vonoprazan Other / unclassified 20 mg Oral